The abstract is read at the publisher; the summary is JClub's.
Device-free auricular acupressure added to standard first-line therapy improves rosacea treatment success at week 8, with an IGA success rate of 56.9% vs 35.3% in sham.
- Why it matters: Specialized device dependence and limited sham-controlled serum biomarker evidence leave uncertainty about neuroimmunomodulatory effects and restrict broader clinical adoption.
- What they did: In a single-center randomized sham-controlled trial of 204 rosacea patients, participants applied Vaccaria segetalis seeds to the bilateral cavum conchae or sham tubercle sites for 8 weeks, with serum LL-37, CGRP, TNF-α, and IL-6 measured at baseline and week 8 plus multispectral vascular imaging at baseline and week 4.
- The result: Active acupressure produced greater biomarker decreases, a higher immediate vascular improvement rate (59.3% vs 7.4%; P<.001), and lower IGA and Clinical Erythema Assessment scores at week 20, with no serious adverse events.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.